Dr Hui Xin Ong (YY) holds a Bachelor of Pharmacy (Hons) and a PhD in Pharmaceutical Science from the University of Sydney. Her research is focused on developing pharmaceutical and medical device technologies that can be used for the treatment of respiratory and infectious diseases, and methodological platforms that can help promote the translation of new discoveries to clinical practice.
Dr Ong's expertise lies in the study of the dynamic interactions between the different biological barriers in the respiratory tract and aerosol particles in a representative manner that captures the true nature of aerosol interactions in the lung. Her research is currently a blend of basic, applied and clinical disciplines.
Dr Ong's work with diverse renowned experts from academia and industry partners has lead to the development of various state-of-the-art pharmaceutical formulations and an outstanding publication record in leading journals in the field.
In 2014 she was awarded the prestigious European Respiratory Society-European Lung Foundation Fellow to work at the University of Southampton (UK). As an emerging leader in the field she has secured approximately $3 million for research projects, infrastructure and education with competitive national and international grants since 2015.
Dr Ong’s well-rounded experience in industry-focused research and education, applied and clinical research aims to translate her research into commercial outcomes that will benefit the healthcare sector and community.